EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dr Lalchandani Labs's enterprise value is ₹133.72 Mil.
Dr Lalchandani Labs's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹4.98 Mil. Therefore, Dr Lalchandani Labs's EV-to-EBITDA for today is 26.86.
The historical rank and industry rank for Dr Lalchandani Labs's EV-to-EBITDA or its related term are showing as below:
BOM:541299'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -1020.95 Med: 4.95 Max: 27.65
Current: 26.85
During the past 11 years, the highest EV-to-EBITDA of Dr Lalchandani Labs was 27.65. The lowest was -1020.95. And the median was 4.95.
BOM:541299's EV-to-EBITDA is ranked worse than 76.11% of 113
companies
in the Medical Diagnostics & Research industry
Industry Median: 16.37
vs BOM:541299: 26.85
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Dr Lalchandani Labs EV-to-EBITDA Historical Data
The historical data trend for Dr Lalchandani Labs's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dr Lalchandani Labs's EV-to-EBITDA
For the Diagnostics & Research subindustry, Dr Lalchandani Labs's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Lalchandani Labs's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dr Lalchandani Labs's EV-to-EBITDA falls into.
Dr Lalchandani Labs's current Enterprise Value is ₹133.72 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dr Lalchandani Labs's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹4.98 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Lalchandani Labs (BOM:541299) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Dr Lalchandani Labs's PE Ratio for today is calculated as:
Dr Lalchandani Labs's share price for today is ₹21.89.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dr Lalchandani Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-1.570.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Dr Lalchandani Labs's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Dr Lalchandani Labs (BOM:541299) Business Description
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:541299 has been successfully added to your 